Immunotherapy approaches targeting regulatory T-cells

Hideya Ohnishi, Takashi Morisaki, Mitsuo Katano

研究成果: ジャーナルへの寄稿評論記事

13 引用 (Scopus)

抄録

The immune system prevents establishment and progression of cancer through innate and adaptive surveillance. However, some cancerous cells successfully evade the immune system. Regulatory T-cells (Tregs) facilitate such evasion. Tregs may be the factor responsible for the limited success of human tumor immunotherapy to date. To improve immunotherapy, it is thought that the number of Tregs and their functions should be inhibited in patients with advanced cancer. In this review, we focus on recent immunotherapy efforts targeting Tregs.

元の言語英語
ページ(範囲)997-1003
ページ数7
ジャーナルAnticancer Research
32
発行部数3
出版物ステータス出版済み - 3 2012

Fingerprint

Regulatory T-Lymphocytes
Immunotherapy
Immune System
Neoplasms

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

これを引用

Ohnishi, H., Morisaki, T., & Katano, M. (2012). Immunotherapy approaches targeting regulatory T-cells. Anticancer Research, 32(3), 997-1003.

Immunotherapy approaches targeting regulatory T-cells. / Ohnishi, Hideya; Morisaki, Takashi; Katano, Mitsuo.

:: Anticancer Research, 巻 32, 番号 3, 03.2012, p. 997-1003.

研究成果: ジャーナルへの寄稿評論記事

Ohnishi, H, Morisaki, T & Katano, M 2012, 'Immunotherapy approaches targeting regulatory T-cells', Anticancer Research, 巻. 32, 番号 3, pp. 997-1003.
Ohnishi, Hideya ; Morisaki, Takashi ; Katano, Mitsuo. / Immunotherapy approaches targeting regulatory T-cells. :: Anticancer Research. 2012 ; 巻 32, 番号 3. pp. 997-1003.
@article{b3a4118df84c4b838129607c9b8628c8,
title = "Immunotherapy approaches targeting regulatory T-cells",
abstract = "The immune system prevents establishment and progression of cancer through innate and adaptive surveillance. However, some cancerous cells successfully evade the immune system. Regulatory T-cells (Tregs) facilitate such evasion. Tregs may be the factor responsible for the limited success of human tumor immunotherapy to date. To improve immunotherapy, it is thought that the number of Tregs and their functions should be inhibited in patients with advanced cancer. In this review, we focus on recent immunotherapy efforts targeting Tregs.",
author = "Hideya Ohnishi and Takashi Morisaki and Mitsuo Katano",
year = "2012",
month = "3",
language = "English",
volume = "32",
pages = "997--1003",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - Immunotherapy approaches targeting regulatory T-cells

AU - Ohnishi, Hideya

AU - Morisaki, Takashi

AU - Katano, Mitsuo

PY - 2012/3

Y1 - 2012/3

N2 - The immune system prevents establishment and progression of cancer through innate and adaptive surveillance. However, some cancerous cells successfully evade the immune system. Regulatory T-cells (Tregs) facilitate such evasion. Tregs may be the factor responsible for the limited success of human tumor immunotherapy to date. To improve immunotherapy, it is thought that the number of Tregs and their functions should be inhibited in patients with advanced cancer. In this review, we focus on recent immunotherapy efforts targeting Tregs.

AB - The immune system prevents establishment and progression of cancer through innate and adaptive surveillance. However, some cancerous cells successfully evade the immune system. Regulatory T-cells (Tregs) facilitate such evasion. Tregs may be the factor responsible for the limited success of human tumor immunotherapy to date. To improve immunotherapy, it is thought that the number of Tregs and their functions should be inhibited in patients with advanced cancer. In this review, we focus on recent immunotherapy efforts targeting Tregs.

UR - http://www.scopus.com/inward/record.url?scp=84858771966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858771966&partnerID=8YFLogxK

M3 - Review article

VL - 32

SP - 997

EP - 1003

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -